ADMA BIOLOGICS, INC. Increase (Decrease) in Derivative Liabilities
ADMA BIOLOGICS, INC. (ADMA) reported Increase (Decrease) in Derivative Liabilities of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2017-02-24
- ADMA BIOLOGICS, INC. increase (decrease) in derivative liabilities for the quarter ending 2016-12-31 was $0.00.
- ADMA BIOLOGICS, INC. increase (decrease) in derivative liabilities for the quarter ending 2016-09-30 was $0.00.
- ADMA BIOLOGICS, INC. increase (decrease) in derivative liabilities for the quarter ending 2016-06-30 was $0.00.
- ADMA BIOLOGICS, INC. increase (decrease) in derivative liabilities for the quarter ending 2016-03-31 was $0.00.
- ADMA BIOLOGICS, INC. increase (decrease) in derivative liabilities for fiscal 2016 was $0.00.
- ADMA BIOLOGICS, INC. increase (decrease) in derivative liabilities for fiscal 2015 was -$67.86K, a 191.26% decline from fiscal 2014.
- ADMA BIOLOGICS, INC. increase (decrease) in derivative liabilities for fiscal 2014 was $74.36K.
- ADMA BIOLOGICS, INC. increase (decrease) in derivative liabilities for fiscal 2013 was -$43.29K.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $0.00 derived: sum of 2 quarters · filed 2017-02-24 | $0.00 derived: sum of 3 quarters · filed 2017-02-24 | $0.00 10-K · filed 2017-02-24 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | $0.00 10-Q · filed 2016-11-10 | $0.00 derived: sum of 4 quarters · filed 2017-02-24 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $0.00 10-Q · filed 2016-08-12 | $0.00 derived: sum of 3 quarters · filed 2017-02-24 | $0.00 derived: sum of 4 quarters · filed 2017-02-24 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-13 | $0.00 derived: sum of 2 quarters · filed 2017-02-24 | $0.00 derived: sum of 3 quarters · filed 2017-02-24 | $0.00 derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $0.00 derived: sum of 2 quarters · filed 2017-02-24 | $0.00 derived: sum of 3 quarters · filed 2017-02-24 | -$67.86K 10-K · filed 2017-02-24 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | -$67.86K 10-Q · filed 2016-11-10 | -$37.70K derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | -$67.86K 10-Q · filed 2016-08-12 | -$37.70K derived: sum of 3 quarters · filed 2016-08-12 | -$23.08K derived: sum of 4 quarters · filed 2016-08-12 |
| 2015-03-31 | -$67.86K 10-Q · filed 2016-05-13 | -$37.70K derived: sum of 2 quarters · filed 2016-05-13 | -$23.08K derived: sum of 3 quarters · filed 2016-05-13 | $11.72K derived: sum of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | $30.16K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $44.78K derived: sum of 2 quarters · filed 2016-03-23 | $79.58K derived: sum of 3 quarters · filed 2016-03-23 | $74.36K 10-K · filed 2016-03-23 |
| 2014-09-30 | $14.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $49.42K derived: sum of 2 quarters · filed 2015-11-10 | $44.20K 10-Q · filed 2015-11-10 | $61.47K derived: sum of 4 quarters · filed 2015-11-10 |
| 2014-06-30 | $34.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $29.58K 10-Q · filed 2015-08-11 | $46.86K derived: sum of 3 quarters · filed 2015-08-11 | $44.05K derived: sum of 4 quarters · filed 2015-08-11 |
| 2014-03-31 | -$5.22K 10-Q · filed 2015-05-12 | $12.06K derived: sum of 2 quarters · filed 2015-05-12 | $9.24K derived: sum of 3 quarters · filed 2015-05-12 | -$11.78K derived: sum of 4 quarters · filed 2015-05-12 |
| 2013-12-31 | $17.28K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $14.46K derived: sum of 2 quarters · filed 2015-03-09 | -$6.56K derived: sum of 3 quarters · filed 2015-03-09 | -$43.29K 10-K · filed 2015-03-09 |
| 2013-09-30 | -$2.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$23.84K derived: sum of 2 quarters · filed 2014-11-10 | -$60.57K 10-Q · filed 2014-11-10 | |
| 2013-06-30 | -$21.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$57.76K 10-Q · filed 2014-08-11 | ||
| 2013-03-31 | -$36.73K 10-Q · filed 2014-05-12 | |||
| 2012-12-31 | $0.00 10-K · filed 2014-03-28 | |||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |